| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
1991-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efdf8b42f724c1bdbda4a24eddb0cd4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_922d648cf2783ac52302d9689b5529f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b65bdd729ff0b5276c4ea52804511c54 |
| publicationDate |
1993-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0556285-A1 |
| titleOfInvention |
Synergistic therapy with combinations of anti-tumor antibodies and biologically active agents |
| abstract |
Disclosed are methods of inhibiting tumor growth and development using a combination of anti-tumor antibodies and biologically active agents such as chemotherapeutic drugs. The combination of the anti-tumor antibody such as the BR96 antibody with a chemotherapeutic drug such as doxorubicin or mitomycin C produces, according to the invention, a synergistic effect of inhibiting tumor development and growth tumor cells. |
| priorityDate |
1990-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |